PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Unit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland.\', \'Department of Health and Community Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland.\', \'University Centre for General Medicine and Public Health, University of Lausanne, Lausanne, Switzerland.\', \'Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States.\', \'Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland.\', \'Department of Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland.\', \'Infection Control Program and World Health Organization Collaborating Centre on Patient Safety, Geneva University Hospitals, Geneva, Switzerland.\', \'Division of Laboratory Medicine, Geneva University Hospitals, Geneva, Switzerland.\', \'Division and Department of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland.\', \'Division of Internal Medicine, Hôpital de la Tour, Geneva, Switzerland.\', \'Department of Woman, Child, and Adolescent Medicine, Geneva University Hospitals, Geneva, Switzerland.\', \'Geneva Centre for Emerging Viral Diseases and Laboratory Virology, Geneva University Hospitals, Geneva, Switzerland.\', \'The members of this group are acknowledged at the end of the article.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.2807/1560-7917.ES.2021.26.43.2100830
?:hasPublicationType
?:journal
  • Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
is ?:pmid of
?:pmid
?:pmid
  • 34713799
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Seroprevalence of anti-SARS-CoV-2 antibodies 6 months into the vaccination campaign in Geneva, Switzerland, 1 June to 7 July 2021.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all